Down syndrome screening: imagining the screening test of the future

References

• Egan JF, Benn PA, Zelop CM, Bolnick A, Gianferrari E, Borgida AF. Down syndrome births in the United States from 1989 to 2001. Am. J. Obstet. Gynecol.191(3), 1044–1048 (2004).
   PubMed Web of Science ®Google Scholar
• Cuckle HS, Wald NJ, Thompson SG. Estimating a woman’s risk of having a pregnancy associated with Down’s syndrome using her age and serum α-fetoprotein level. Br. J. Obstet. Gynaecol.94(5), 387–402 (1987).
   PubMedGoogle Scholar
• Wald NJ, Cuckle HS, Densem Jw et al. Maternal serum screening for Down’s syndrome in early pregnancy. BMJ297(6653), 883–887 (1988).
   PubMed Web of Science ®Google Scholar
• Cuckle HS, Arbuzova S. Multimarker serum screening for chromosomal abnormalities. In: Genetic Disorders and the Fetus; Diagnosis, Prevention and Treatment. Milunsky A (Ed.). Johns Hopkins University Press, MD, USA 795–835 (2004).
   Google Scholar
• Wald NJ, Hackshaw AK. Combining ultrasound and biochemistry in first-trimester screening for Down’s syndrome. Prenat. Diagn.17(9), 821–829 (1997).
   PubMed Web of Science ®Google Scholar
• Cuckle H, Benn P, Wright D. Down syndrome screening in the first and/or second trimester: model predicted performance using meta-analysis parameters. Semin. Perinatol.29(4), 252–257 (2005).
   PubMed Web of Science ®Google Scholar
• Schielen PC, Van Leeuwen-Spruijt M, Belmouden I, Elvers LH, Jonker M, Loeber JG. Multi-centre first-trimester screening for Down syndrome in the netherlands in routine clinical practice. Prenat. Diagn.26(8), 711–718 (2006).
   PubMed Web of Science ®Google Scholar
• Wright D, Spencer K, Nix B. First trimester screening for Down syndrome using free β hCG, total hCG and PAPP-A: an exploratory study. Prenat. Diagn.27(12), 1118–1122 (2007).
   PubMed Web of Science ®Google Scholar
• Fan HC, Blumenfeld YJ, Chitkara U, Hudgins L, Quake SR. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc. Natl Acad. Sci. USA105(42), 16266–16271 (2008).
   PubMed Web of Science ®Google Scholar
• Go AT, Visser A, Mulders MA, Blankenstein MA, Van Vugt JM, Oudejans CB. 44 single-nucleotide polymorphisms expressed by placental RNA: assessment for use in noninvasive prenatal diagnosis of trisomy 21. Clin. Chem.53(12), 2223–2224 (2007).
   PubMed Web of Science ®Google Scholar
• Lo YM. Fetal DNA in maternal plasma. Ann. NY Acad. Sci.906, 141–147 (2000).
   PubMed Web of Science ®Google Scholar
• Bromage SJ, Lang AK, Atkinson I, Searle RF. Abnormal TGFβ levels in the amniotic fluid of Down syndrome pregnancies. Am. J. Reprod. Immunol.44(4), 205–210 (2000).
   PubMed Web of Science ®Google Scholar
• Vesce F, Scapoli C, Giovannini G et al. Cytokine imbalance in pregnancies with fetal chromosomal abnormalities. Hum. Reprod.17(3), 803–808 (2002).
   PubMed Web of Science ®Google Scholar
• Benirschke K, Kaufmann P. Pathology of the Human Placenta. Springer (2000).
   Google Scholar
• Malassine A, Cronier L. Hormones and human trophoblast differentiation: a review. Endocrine19(1), 3–11 (2002).
   PubMed Web of Science ®Google Scholar
• Evain-Brion D, Malassine A. Human placenta as an endocrine organ. Growth Horm. IGF Res.13(Suppl. A), S34–S37 (2003).
   PubMed Web of Science ®Google Scholar
• Gude NM, Roberts CT, Kalionis B, King RG. Growth and function of the normal human placenta. Thromb. Res.114(5–6), 397–407 (2004).
   PubMed Web of Science ®Google Scholar
• Lunghi L, Ferretti ME, Medici S, Biondi C, Vesce F. Control of human trophoblast function. Reprod. Biol. Endocrinol.5, 6 (2007).
   PubMed Web of Science ®Google Scholar
• Frendo JL, Therond P, Bird T et al. Overexpression of copper zinc superoxide dismutase impairs human trophoblast cell fusion and differentiation. Endocrinology142(8), 3638–3648 (2001).
   PubMed Web of Science ®Google Scholar
• Alsat E, Wyplosz P, Malassine A et al. Hypoxia impairs cell fusion and differentiation process in human cytotrophoblast, in vitro. J. Cell. Physiol.168(2), 346–353 (1996).
   PubMed Web of Science ®Google Scholar
• Esterman A, Greco MA, Mitani Y, Finlay TH, Ismail-Beigi F, Dancis J. The effect of hypoxia on human trophoblast in culture: morphology, glucose transport and metabolism. Placenta18(2–3), 129–136 (1997).
   PubMed Web of Science ®Google Scholar
• Qumsiyeh MB, Kim KR, Ahmed MN, Bradford W. Cytogenetics and mechanisms of spontaneous abortions: increased apoptosis and decreased cell proliferation in chromosomally abnormal villi. Cytogenet. Cell Genet.88(3–4), 230–235 (2000).
   PubMedGoogle Scholar
• Banerjee S, Smallwood A, Nargund G, Campbell S. Placental morphogenesis in pregnancies with Down’s syndrome might provide a clue to pre-eclampsia. Placenta23(2–3), 172–174 (2002).
   PubMed Web of Science ®Google Scholar
• Pidoux G, Guibourdenche J, Frendo Jl et al. Impact of trisomy 21 on human trophoblast behaviour and hormonal function. Placenta25(Suppl. A), S79–S84 (2004).
   PubMed Web of Science ®Google Scholar
• Frendo JL, Vidaud M, Guibourdenche J et al. Defect of villous cytotrophoblast differentiation into syncytiotrophoblast in Down’s syndrome. J. Clin. Endocrinol. Metab.85(10), 3700–3707 (2000).
   PubMed Web of Science ®Google Scholar
• Massin N, Frendo JL, Guibourdenche J et al. Defect of syncytiotrophoblast formation and human chorionic gonadotropin expression in Down’s syndrome. Placenta22(Suppl. A), S93–S97 (2001).
   PubMed Web of Science ®Google Scholar
• Roberts L, Sebire NJ, Fowler D, Nicolaides KH. Histomorphological features of chorionic villi at 10–14 weeks of gestation in trisomic and chromosomally normal pregnancies. Placenta21(7), 678–683 (2000).
   PubMed Web of Science ®Google Scholar
• Metzenbauer M, Hafner E, Schuchter K, Philipp K. First-trimester placental volume as a marker for chromosomal anomalies: preliminary results from an unselected population. Ultrasound Obstet. Gynecol.19(3), 240–242 (2002).
   PubMed Web of Science ®Google Scholar
• Wright A, Zhou Y, Weier Jf et al. Trisomy 21 is associated with variable defects in cytotrophoblast differentiation along the invasive pathway. Am. J. Med. Genet. A130A(4), 354–364 (2004).
   PubMed Web of Science ®Google Scholar
• Kratzer PG, Golbus MS, Schonberg SA, Heilbron DC, Taylor RN. Cytogenetic evidence for enhanced selective miscarriage of trisomy 21 pregnancies with advancing maternal age. Am. J. Med. Genet.44(5), 657–663 (1992).
   PubMed Web of Science ®Google Scholar
• Macintosh MC, Wald NJ, Chard T et al. Selective miscarriage of Down’s syndrome fetuses in women aged 35 years and older. Br. J. Obstet. Gynaecol.102(10), 798–801 (1995).
   PubMedGoogle Scholar
• Kuhn P, Brizot ML, Pandya PP, Snijders RJ, Nicolaides KH. Crown–rump length in chromosomally abnormal fetuses at 10 to 13 weeks’ gestation. Am. J. Obstet. Gynecol.172(1 Pt 1), 32–35 (1995).
   PubMed Web of Science ®Google Scholar
• Minguillon C, Eiben B, Bahr-Porsch S, Vogel M, Hansmann I. The predictive value of chorionic villus histology for identifying chromosomally normal and abnormal spontaneous abortions. Hum. Genet.82(4), 373–376 (1989).
   PubMed Web of Science ®Google Scholar
• Sebire NJ, Fowler D, Roberts L, Mahmood S, Nicolaides KH. Short communication: trophoblast proliferation is increased in chorionic villi from pregnancies with fetal trisomy 18. Placenta21(5–6), 584–586 (2000).
   PubMed Web of Science ®Google Scholar
• Ohlsson R, Larsson E, Nilsson O, Wahlstrom T, Sundstrom P. Blastocyst implantation precedes induction of insulin-like growth factor II gene expression in human trophoblasts. Development106(3), 555–559 (1989).
   PubMed Web of Science ®Google Scholar
• Thomsen BM, Clausen HV, Larsen LG, Nurnberg L, Ottesen B, Thomsen HK. Patterns in expression of insulin-like growth factor-II and of proliferative activity in the normal human first and third trimester placenta demonstrated by non-isotopic in situ hybridization and immunohistochemical staining for mib-1. Placenta18(2–3), 145–154 (1997).
   PubMed Web of Science ®Google Scholar
• Hiden U, Glitzner E, Hartmann M, Desoye G. Insulin and the IGF system in the human placenta of normal and diabetic pregnancies. J. Anat.215(1), 60–68 (2009).
   PubMed Web of Science ®Google Scholar
• Clemmons DR. Insulin-like growth factor binding proteins and their role in controlling IGF actions. Cytokine Growth Factor Rev.8(1), 45–62 (1997).
   PubMedGoogle Scholar
• Mckinnon T, Chakraborty C, Gleeson LM, Chidiac P, Lala PK. Stimulation of human extravillous trophoblast migration by IGF-II is mediated by IGF type 2 receptor involving inhibitory G protein(s) and phosphorylation of MAPK. J. Clin. Endocrinol. Metab.86(8), 3665–3674 (2001).
   PubMed Web of Science ®Google Scholar
• Han VK, Bassett N, Walton J, Challis JR. The expression of insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) genes in the human placenta and membranes: evidence for IGF-IGFBP interactions at the feto–maternal interface. J. Clin. Endocrinol. Metab.81(7), 2680–2693 (1996).
   PubMed Web of Science ®Google Scholar
• Hamilton GS, Lysiak JJ, Han VK, Lala PK. Autocrine-paracrine regulation of human trophoblast invasiveness by insulin-like growth factor (IGF)-II and IGF-binding protein (IGFBP)-1. Exp. Cell Res.244(1), 147–156 (1998).
   PubMed Web of Science ®Google Scholar
• Irving JA, Lala PK. Functional role of cell surface integrins on human trophoblast cell migration: regulation by TGF-β, IGF-II, and IGFBP-1. Exp. Cell Res.217(2), 419–427 (1995).
   PubMed Web of Science ®Google Scholar
• Bonno M, Oxvig C, Kephart Gm et al. Localization of pregnancy-associated plasma protein-a and colocalization of pregnancy-associated plasma protein-a messenger ribonucleic acid and eosinophil granule major basic protein messenger ribonucleic acid in placenta. Lab. Invest.71(4), 560–566 (1994).
   PubMed Web of Science ®Google Scholar
• Giudice LC, Conover CA, Bale L et al. Identification and regulation of the IGFBP-4 protease and its physiological inhibitor in human trophoblasts and endometrial stroma: evidence for paracrine regulation of IGF-II bioavailability in the placental bed during human implantation. J. Clin. Endocrinol. Metab.87(5), 2359–2366 (2002).
   PubMed Web of Science ®Google Scholar
• Wang HX, Zhao YG, Wang Hm et al. Expression of adamalysin 19/ADAM19 in the endometrium and placenta of rhesus monkey (Macaca mulatta) during early pregnancy. Mol. Hum. Reprod.11(6), 429–435 (2005).
   PubMed Web of Science ®Google Scholar
• Hofmann GE, Scott Rt JR, Bergh PA, Deligdisch L. Immunohistochemical localization of epidermal growth factor in human endometrium, decidua, and placenta. J. Clin. Endocrinol. Metab.73(4), 882–887 (1991).
   PubMed Web of Science ®Google Scholar
• Garcia-Lloret MI, Yui J, Winkler-Lowen B, Guilbert LJ. Epidermal growth factor inhibits cytokine-induced apoptosis of primary human trophoblasts. J. Cell. Physiol.167(2), 324–332 (1996).
   PubMed Web of Science ®Google Scholar
• Morrish DW, Bhardwaj D, Dabbagh LK, Marusyk H, Siy O. Epidermal growth factor induces differentiation and secretion of human chorionic gonadotropin and placental lactogen in normal human placenta. J. Clin. Endocrinol. Metab.65(6), 1282–1290 (1987).
   PubMed Web of Science ®Google Scholar
• Bass KE, Morrish D, Roth I et al. Human cytotrophoblast invasion is up-regulated by epidermal growth factor: evidence that paracrine factors modify this process. Dev. Biol.164(2), 550–561 (1994).
   PubMed Web of Science ®Google Scholar
• Li RH, Zhuang LZ. The effects of growth factors on human normal placental cytotrophoblast cell proliferation. Hum. Reprod.12(4), 830–834 (1997).
   PubMed Web of Science ®Google Scholar
• Bischof P, Campana A. Molecular mediators of implantation. Baillieres Best Pract. Res. Clin. Obstet. Gynaecol.14(5), 801–814 (2000).
   PubMed Web of Science ®Google Scholar
• Graham CH, Lysiak JJ, Mccrae KR, Lala PK. Localization of transforming growth factor-β at the human fetal-maternal interface: role in trophoblast growth and differentiation. Biol. Reprod.46(4), 561–572 (1992).
   PubMed Web of Science ®Google Scholar
• Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr. Rev.18(1), 4–25 (1997).
   PubMed Web of Science ®Google Scholar
• Connolly DT, Heuvelman DM, Nelson R et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J. Clin. Invest.84(5), 1470–1478 (1989).
   PubMed Web of Science ®Google Scholar
• Khaliq A, Dunk C, Jiang J et al. Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for “placental hyperoxia” in intrauterine growth restriction. Lab. Invest.79(2), 151–170 (1999).
   PubMed Web of Science ®Google Scholar
• Huppertz B, Kertschanska S, Frank HG, Gaus G, Funayama H, Kaufmann P. Extracellular matrix components of the placental extravillous trophoblast: immunocytochemistry and ultrastructural distribution. Histochem. Cell Biol.106(3), 291–301 (1996).
   PubMed Web of Science ®Google Scholar
• Marzusch K, Ruck P, Dietl JA, Horny HP, Kaiserling E. Immunohistochemical localization of tissue inhibitor of metalloproteinases-2 (TIMP-2) in first trimester human placental decidua. Eur. J. Obstet. Gynecol. Reprod. Biol.68(1–2), 105–107 (1996).
   PubMed Web of Science ®Google Scholar
• Ruck P, Marzusch K, Horny HP, Dietl J, Kaiserling E. The distribution of tissue inhibitor of metalloproteinases-2 (TIMP-2) in the human placenta. Placenta17(4), 263–266 (1996).
   PubMed Web of Science ®Google Scholar
• Hayakawa T, Yamashita K, Ohuchi E, Shinagawa A. Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). J. Cell. Sci.107(Pt 9), 2373–2379 (1994).
   PubMed Web of Science ®Google Scholar
• Satoh T, Kobayashi K, Yamashita S, Kikuchi M, Sendai Y, Hoshi H. Tissue inhibitor of metalloproteinases (TIMP-1) produced by granulosa and oviduct cells enhances in vitro development of bovine embryo. Biol. Reprod.50(4), 835–844 (1994).
   PubMed Web of Science ®Google Scholar
• Shi QJ, Lei ZM, Rao CV, Lin J. Novel role of human chorionic gonadotropin in differentiation of human cytotrophoblasts. Endocrinology132(3), 1387–1395 (1993).
   PubMed Web of Science ®Google Scholar
• Licht P, Cao H, Lei ZM, Rao CV, Merz WE. Novel self-regulation of human chorionic gonadotropin biosynthesis in term pregnancy human placenta. Endocrinology133(6), 3014–3025 (1993).
   PubMed Web of Science ®Google Scholar
• Kovalevskaya G, Genbacev O, Fisher SJ, Caceres E, O’Connor JF. Trophoblast origin of hCG isoforms: cytotrophoblasts are the primary source of choriocarcinoma-like hCG. Mol. Cell. Endocrinol.194(1–2), 147–155 (2002).
   PubMed Web of Science ®Google Scholar
• Alsat E, Guibourdenche J, Couturier A, Evain-Brion D. Physiological role of human placental growth hormone. Mol. Cell. Endocrinol.140(1–2), 121–127 (1998).
   PubMed Web of Science ®Google Scholar
• Zeck W, Widberg C, Maylin E et al. Regulation of placental growth hormone secretion in a human trophoblast model – the effects of hormones and adipokines. Pediatr. Res.63(4), 353–357 (2008).
   PubMed Web of Science ®Google Scholar
• Margetic S, Gazzola C, Pegg GG, Hill RA. Leptin: a review of its peripheral actions and interactions. Int. J. Obes. Relat. Metab. Disord.26(11), 1407–1433 (2002).
   PubMed Web of Science ®Google Scholar
• Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature359(6398), 843–845 (1992).
   PubMed Web of Science ®Google Scholar
• Falanga V, Takagi H, Ceballos PI, Pardes JB. Low oxygen tension decreases receptor binding of peptide growth factors in dermal fibroblast cultures. Exp. Cell Res.213(1), 80–84 (1994).
   PubMed Web of Science ®Google Scholar
• Caniggia I, Mostachfi H, Winter J et al. Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFb(3). J. Clin. Invest.105(5), 577–587 (2000).
   PubMed Web of Science ®Google Scholar
• Genbacev O, Joslin R, Damsky CH, Polliotti BM, Fisher SJ. Hypoxia alters early gestation human cytotrophoblast differentiation/invasion in vitro and models the placental defects that occur in preeclampsia. J. Clin. Invest.97(2), 540–550 (1996).
   PubMed Web of Science ®Google Scholar
• Autio-Harmainen H, Sandberg M, Pihlajaniemi T, Vuorio E. Synthesis of laminin and type IV collagen by trophoblastic cells and fibroblastic stromal cells in the early human placenta. Lab. Invest.64(4), 483–491 (1991).
   PubMed Web of Science ®Google Scholar
• Graham CH, Lala PK. Mechanisms of placental invasion of the uterus and their control. Biochem. Cell Biol.70(10–11), 867–874 (1992).
   PubMed Web of Science ®Google Scholar
• Bischof P, Meisser A, Campana A, Tseng L. Effects of decidua-conditioned medium and insulin-like growth factor binding protein-1 on trophoblastic matrix metalloproteinases and their inhibitors. Placenta19(7), 457–464 (1998).
   PubMed Web of Science ®Google Scholar
• Nayak NR, Giudice LC. Comparative biology of the IGF system in endometrium, decidua, and placenta, and clinical implications for foetal growth and implantation disorders. Placenta24(4), 281–296 (2003).
   PubMed Web of Science ®Google Scholar
• Bischof P, Meisser A, Campana A. Control of MMP-9 expression at the maternal–fetal interface. J. Reprod. Immunol.55(1–2), 3–10 (2002).
   PubMed Web of Science ®Google Scholar
• Martin DC, Fowlkes JL, Babic B, Khokha R. Insulin-like growth factor ii signaling in neoplastic proliferation is blocked by transgenic expression of the metalloproteinase inhibitor TIMP-1. J. Cell Biol.146(4), 881–892 (1999).
   PubMed Web of Science ®Google Scholar
• Yu Q, Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis. Genes Dev.14(2), 163–176 (2000).
   PubMed Web of Science ®Google Scholar
• Evain-Brion D, Alsat E. Epidermal growth factor receptor and human fetoplacental development. J. Pediatr. Endocrinol.7(4), 295–302 (1994).
   PubMedGoogle Scholar
• Sawicki G, Radomski MW, Winkler-Lowen B, Krzymien A, Guilbert LJ. Polarized release of matrix metalloproteinase-2 and -9 from cultured human placental syncytiotrophoblasts. Biol. Reprod.63(5), 1390–1395 (2000).
   PubMed Web of Science ®Google Scholar
• Chung IB, Yelian FD, Zaher Fm et al. Expression and regulation of vascular endothelial growth factor in a first trimester trophoblast cell line. Placenta21(4), 320–324 (2000).
   PubMed Web of Science ®Google Scholar
• Feinberg RF, Kliman HJ, Wang CL. Transforming growth factor-β stimulates trophoblast oncofetal fibronectin synthesis in vitro: implications for trophoblast implantation in vivo. J. Clin. Endocrinol. Metab.78(5), 1241–1248 (1994).
   PubMed Web of Science ®Google Scholar
• Mazella J, Tang M, Tseng L. Disparate effects of relaxin and TGFβ1: relaxin increases, but TGFβ1 inhibits, the relaxin receptor and the production of IGFBP-1 in human endometrial stromal/decidual cells. Hum. Reprod.19(7), 1513–1518 (2004).
   PubMed Web of Science ®Google Scholar
• Graham CH. Effect of transforming growth factor-β on the plasminogen activator system in cultured first trimester human cytotrophoblasts. Placenta18(2–3), 137–143 (1997).
   PubMed Web of Science ®Google Scholar
• Atfi A, Dumont E, Colland F et al. The disintegrin and metalloproteinase ADAM12 contributes to TGF-β signaling through interaction with the type II receptor. J. Cell Biol.178(2), 201–208 (2007).
   PubMed Web of Science ®Google Scholar
• Morrish DW, Dakour J, Li H. Functional regulation of human trophoblast differentiation. J. Reprod. Immunol.39(1–2), 179–195 (1998).
   PubMed Web of Science ®Google Scholar
• Fukushima K, Miyamoto S, Tsukimori K et al. Tumor necrosis factor and vascular endothelial growth factor induce endothelial integrin repertories, regulating endovascular differentiation and apoptosis in a human extravillous trophoblast cell line. Biol. Reprod.73(1), 172–179 (2005).
   PubMed Web of Science ®Google Scholar
• Anteby EY, Greenfield C, Natanson-Yaron S et al. Vascular endothelial growth factor, epidermal growth factor and fibroblast growth factor-4 and -10 stimulate trophoblast plasminogen activator system and metalloproteinase-9. Mol. Hum. Reprod.10(4), 229–235 (2004).
   PubMed Web of Science ®Google Scholar
• Licht P, Russu V, Wildt L. On the role of human chorionic gonadotropin (hCG) in the embryo–endometrial microenvironment: implications for differentiation and implantation. Semin. Reprod. Med.19(1), 37–47 (2001).
   PubMed Web of Science ®Google Scholar
• Zygmunt M, Mckinnon T, Herr F, Lala PK, Han VK. hCG increases trophoblast migration in vitro via the insulin-like growth factor-II/mannose-6 phosphate receptor. Mol. Hum. Reprod.11(4), 261–267 (2005).
   PubMed Web of Science ®Google Scholar
• Milwidsky A, Finci-Yeheskel Z, Yagel S, Mayer M. Gonadotropin-mediated inhibition of proteolytic enzymes produced by human trophoblast in culture. J. Clin. Endocrinol. Metab.76(5), 1101–1105 (1993).
   PubMed Web of Science ®Google Scholar
• Alsat E, Guibourdenche J, Luton D, Frankenne F, Evain-Brion D. Human placental growth hormone. Am. J. Obstet. Gynecol.177(6), 1526–1534 (1997).
   PubMed Web of Science ®Google Scholar
• Lacroix MC, Guibourdenche J, Frendo JL, Muller F, Evain-Brion D. Human placental growth hormone – a review. Placenta23(Suppl. A), S87–S94 (2002).
   PubMed Web of Science ®Google Scholar
• Cameo P, Bischof P, Calvo JC. Effect of leptin on progesterone, human chorionic gonadotropin, and interleukin-6 secretion by human term trophoblast cells in culture. Biol. Reprod.68(2), 472–477 (2003).
   PubMed Web of Science ®Google Scholar
• Islami D, Bischof P, Chardonnens D. Possible interactions between leptin, gonadotrophin-releasing hormone (GNRH-I and II) and human chorionic gonadotrophin (hCG). Eur. J. Obstet. Gynecol. Reprod. Biol.110(2), 169–175 (2003).
   PubMed Web of Science ®Google Scholar
• Islami D, Bischof P, Chardonnens D. Modulation of placental vascular endothelial growth factor by leptin and hCG. Mol. Hum. Reprod.9(7), 395–398 (2003).
   PubMed Web of Science ®Google Scholar
• Ognibene A, Ciuti R, Tozzi P, Messeri G. Maternal serum superoxide dismutase (SOD): a possible marker for screening Down syndrome affected pregnancies. Prenat. Diagn.19(11), 1058–1060 (1999).
   PubMed Web of Science ®Google Scholar
• Debieve F, Moiset A, Thomas K, Pampfer S, Hubinont C. Vascular endothelial growth factor and placenta growth factor concentrations in Down’s syndrome and control pregnancies. Mol. Hum. Reprod.7(8), 765–770 (2001).
   PubMed Web of Science ®Google Scholar
• Zaragoza E, Akolekar R, Poon LC, Pepes S, Nicolaides KH. Maternal serum placental growth factor at 11–13 weeks in chromosomally abnormal pregnancies. Ultrasound Obstet. Gynecol.33(4), 382–386 (2009).
   PubMed Web of Science ®Google Scholar
• Koster MP, Pennings JL, Imholz S et al. Bead-based multiplexed immunoassays to identify new biomarkers in maternal serum to improve first trimester Down syndrome screening. Prenat. Diagn.29(9), 857–862 (2009).
   PubMed Web of Science ®Google Scholar
• Moghadam S, Engel W, Bougoussa M, Hennen G, Igout A, Sancken U. Maternal serum placental growth hormone and insulin like growth factor binding proteins 1 and 3 in pregnancies affected by fetal aneuploidy and other abnormalities: implications for prenatal diagnosis of trisomy 21. Fetal Diagn. Ther.13(5), 291–297 (1998).
   PubMed Web of Science ®Google Scholar
• Miell JP, Langford KS, Jones Js et al. The maternal insulin-like growth factor (IGF) and IGF-binding protein response to trisomic pregnancy during the first trimester: a possible diagnostic tool for trisomy 18 pregnancies. J. Clin. Endocrinol. Metab.82(1), 287–292 (1997).
   PubMed Web of Science ®Google Scholar
• Laigaard J, Sorensen T, Frohlich C et al. ADAM12: a novel first-trimester maternal serum marker for Down syndrome. Prenat. Diagn.23(13), 1086–1091 (2003).
   PubMed Web of Science ®Google Scholar
• Wortelboer EJ, Linskens IH, Koster Mp et al. ADAM12S as a first-trimester screening marker of trisomy. Prenat. Diagn.29(9), 866–869 (2009).
   PubMed Web of Science ®Google Scholar
• Frendo JL, Guibourdenche J, Pidoux G et al. Trophoblast production of a weakly bioactive human chorionic gonadotropin in trisomy 21-affected pregnancy. J. Clin. Endocrinol. Metab.89(2), 727–732 (2004).
   PubMed Web of Science ®Google Scholar
• Pandian R, Cole LA, Palomaki GE. Second-trimester maternal serum invasive trophoblast antigen: a marker for Down syndrome screening. Clin. Chem.50(8), 1433–1435 (2004).
   PubMed Web of Science ®Google Scholar
• Weinans MJ, Sancken U, Pandian R et al. Invasive trophoblast antigen (hyperglycosylated human chorionic gonadotropin) as a first-trimester serum marker for Down syndrome. Clin. Chem.51(7), 1276–1279 (2005).
   PubMed Web of Science ®Google Scholar
• Christiansen M. Placental growth hormone and growth hormone binding protein are first trimester maternal serum markers of Down syndrome. Prenat. Diagn.29(13), 1249–1255 (2009).
   PubMed Web of Science ®Google Scholar
• Christiansen M, Sorensen TL, Norgaard-Pedersen B. Human placental lactogen is a first-trimester maternal serum marker of Down syndrome. Prenat. Diagn.27(1), 1–5 (2007).
   PubMed Web of Science ®Google Scholar
• Hedley P, Christiansen M. Serum leptin in first-trimester Down syndrome pregnancies. Prenat. Diagn.28(6), 475–477 (2008).
   PubMed Web of Science ®Google Scholar
• Poon LC, Nekrasova E, Anastassopoulos P, Livanos P, Nicolaides KH. First-trimester maternal serum matrix metalloproteinase-9 (MMP-9) and adverse pregnancy outcome. Prenat. Diagn.29(6), 553–559 (2009).
   PubMed Web of Science ®Google Scholar
• Knofler M. Critical growth factors and signalling pathways controlling human trophoblast invasion. Int. J. Dev. Biol.54(2–3), 269–280 (2010).
   PubMed Web of Science ®Google Scholar
• Cross JC, Anson-Cartwright L, Scott IC. Transcription factors underlying the development and endocrine functions of the placenta. Recent Prog. Horm. Res.57, 221–234 (2002).
   PubMedGoogle Scholar
• Palomaki GE, Wright DE, Summers Am et al. Repeated measurement of pregnancy-associated plasma protein-a (PAPP-a) in Down syndrome screening: a validation study. Prenat. Diagn.26(8), 730–739 (2006).
   PubMed Web of Science ®Google Scholar
• Huppertz B, Sammar M, Chefetz I, Neumaier-Wagner P, Bartz C, Meiri H. Longitudinal determination of serum placental protein 13 during development of preeclampsia. Fetal Diagn. Ther.24(3), 230–236 (2008).
   PubMed Web of Science ®Google Scholar
• Lo YM. Noninvasive prenatal detection of fetal chromosomal aneuploidies by maternal plasma nucleic acid analysis: a review of the current state of the art. BJOG116(2), 152–157 (2009).
   PubMed Web of Science ®Google Scholar
• Pennings JL, Koster MP, Rodenburg W, Schielen PC, De Vries A. Discovery of novel serum biomarkers for prenatal Down syndrome screening by integrative data mining. PLoS ONE4(11), e8010 (2009).
   PubMedGoogle Scholar
• Busch A, Michel S, Hoppe C, Driesch D, Claussen U, Von Eggeling F. Proteome analysis of maternal serum samples for trisomy 21 pregnancies using ProteinChip arrays and bioinformatics. J. Histochem. Cytochem.53(3), 341–343 (2005).
   PubMed Web of Science ®Google Scholar
• Kolialexi A, Tsangaris GT, Papantoniou N et al. Application of proteomics for the identification of differentially expressed protein markers for Down syndrome in maternal plasma. Prenat. Diagn.28(8), 691–698 (2008).
   PubMed Web of Science ®Google Scholar
• Nagalla SR, Canick JA, Jacob T et al. Proteomic analysis of maternal serum in Down syndrome: identification of novel protein biomarkers. J. Proteome Res.6(4), 1245–1257 (2007).
   PubMed Web of Science ®Google Scholar
• Tsangaris GT, Karamessinis P, Kolialexi A et al. Proteomic analysis of amniotic fluid in pregnancies with Down syndrome. Proteomics6(15), 4410–4419 (2006).
   PubMed Web of Science ®Google Scholar